MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
0.9153
-0.0645
-6.58%
After Hours: 0.9336 +0.0183 +2.00% 19:18 12/17 EST
OPEN
0.9700
PREV CLOSE
0.9798
HIGH
1.000
LOW
0.9110
VOLUME
135.68K
TURNOVER
--
52 WEEK HIGH
3.610
52 WEEK LOW
0.7449
MARKET CAP
5.02M
P/E (TTM)
-0.2546
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLMD last week (1208-1212)?
Weekly Report · 2d ago
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
TipRanks · 3d ago
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
TipRanks · 12/08 14:17
Galmed Pharmaceuticals Announces Phase 1/2 Study of Aramchol and Regorafenib in Liver Cancer
Reuters · 12/08 13:30
Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting
PR Newswire · 12/08 13:30
Weekly Report: what happened at GLMD last week (1201-1205)?
Weekly Report · 12/08 09:14
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
TipRanks · 12/04 13:58
Galmed Pharma Granted Patent In South Korea For Aramchol And Rezdiffra Combination Therapy In NASH/MASH And Liver Fibrosis
Benzinga · 12/04 13:36
More
About GLMD
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.